Home › Funds › Symphony Financial, Ltd. Co. › JNJ

Symphony Financial, Ltd. Co. position in JNJ

JOHNSON & JOHNSON · Health Care

Symphony Financial, Ltd. Co. reported holding 49,031 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$13.1M, representing 1.16% of its reported portfolio and ranking #22 among its reported holdings. Symphony Financial, Ltd. Co. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)49.03K sh
Reported value held$13.05M
Portfolio Weight1.16%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Symphony Financial, Ltd. Co.'s JNJ position evolved

Symphony Financial, Ltd. Co. first disclosed a stake in JNJ in Q3 2023 at 9,395 shares (US$1.5M). The position peaked in Q3 2026 at 49,031 shares, worth US$13.1M. Across 13 filings, Symphony Financial, Ltd. Co. increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 49,031 shares valued at US$13.1M — an increase of 6,966 shares quarter over quarter.. Notable position changes include a 118% increase in Q4 2023 (shares rose 1% over the following quarter), a 97% increase in Q2 2024 (shares rose 11% over the following quarter), a 521% increase in Q2 2025 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 9.39K $1.46M New
Q4 2023 20.47K $3.29M Add
Q1 2024 18.03K $2.85M Reduce
Q2 2024 35.52K $5.18M Add
Q3 2024 37.36K $6.03M Add
Q4 2024 35.38K $5.22M Reduce
Q1 2025 7.55K $1.19M Reduce
Q2 2025 46.90K $7.20M Add
Q3 2025 45.43K $8.35M Reduce
Q4 2025 39.79K $8.23M Reduce
Q1 2026 41.66K $10.13M Add
Q2 2026 42.06K $10.86M Add
Q3 2026 49.03K $13.05M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$41.76B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Symphony Financial, Ltd. Co. held JNJ?

Symphony Financial, Ltd. Co. has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Symphony Financial, Ltd. Co.'s current position in JNJ?

As of Q3 2026, Symphony Financial, Ltd. Co. holds 49.03K shares of JNJ (JOHNSON & JOHNSON), valued at $13.05M, representing 1.16% of its reported portfolio and ranking #22.

Has Symphony Financial, Ltd. Co. been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Symphony Financial, Ltd. Co. increased its position in JNJ. The position peaked in Q3 2026 at 49.03K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.